Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

new blog post

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
buccaneer1961 Member Profile
Member Level 
Followed By 294
Posts 45,085
Boards Moderated 16
Alias Born 02/24/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2014 6:00:08 AM
Provectus’ Intralesional PV-10 Clinical Data to Be Presented to the 2014 International Congress of the Society for Melanoma... "Business Wire" - 10/16/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 6:04:52 AM
Provectus’ Intralesional PV-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting "Business Wire" - 10/15/2014 6:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/15/2014 5:59:30 AM
INC Research Signs Agreement to Perform FDA Due Diligence Audit of Regulatory Documents for Provectus Biopharmaceuticals "Business Wire" - 10/14/2014 9:53:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/14/2014 9:39:06 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/8/2014 6:00:54 AM
Provectus’ Intralesional PV-10 Clinical Data to Be Presented to the Eurasian Federation of Oncology "Business Wire" - 10/8/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/7/2014 6:01:59 AM
Provectus’ Intralesional PV-10 to Be Presented at the 2014 Beijing International Melanoma Congress "Business Wire" - 10/7/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2014 6:15:15 AM
Provectus Biopharmaceuticals Data Presented At ESMO 2014 Congress Show Ablative, Bystander Effects Of PV-10 "Business Wire" - 9/29/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 6:02:58 AM
Provectus Biopharmaceuticals’ PV-10 Clinical Data on Melanoma Now Available for European Society for Medical Oncology 2014 ... "Business Wire" - 9/24/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/23/2014 6:04:20 AM
Provectus’ Intralesional Pv-10 and Co-Inhibitory Blockade Data to Be Presented at SITC 29th Annual Meeting "Business Wire" - 9/23/2014 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2014 6:08:53 AM
Provectus Biopharmaceuticals Appoints Christopher Kaplan to Its Strategic Advisory Board "Business Wire" - 9/22/2014 6:00:00 AM
プロヴェクタスが国薬-中国医薬工業研究総院および国薬一心制薬有限公司と了解覚書を交わす "Business Wire" - 8/21/2014 5:46:00 AM
Provectus Signs Memorandum of Understanding with Sinopharm-China State Institute of Pharmaceutical Industry, & Sinopharm A-TH... "Business Wire" - 8/18/2014 9:19:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/18/2014 8:30:16 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2014 6:03:48 AM
Provectus Biopharmaceuticals Inc. to Commence Series of Quarterly Conference Calls on Thursday, August 7, 2014 "Business Wire" - 8/6/2014 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/31/2014 6:16:47 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist